12:00 AM
 | 
Jan 02, 2012
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Zalicus completes debt financing

Zalicus Inc. (NASDAQ:ZLCS), Cambridge, Mass.
Business: Autoimmune, Neurology, Inflammation
Date completed: 12/19/11
Type: Debt financing
Raised: $8.5 million
Investor: Oxford...

Read the full 78 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >